Clarification18 Sept 2026, 03:36 pm
Astec Lifesciences Responds to Stock Exchange Volume Inquiry
AI Summary
Astec Lifesciences Ltd has responded to a stock exchange inquiry regarding a significant increase in trading volume. The company confirmed its compliance with SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015, and the Prohibition of Insider Trading (PIT) Regulations, 2015. They stated that all material information impacting share price has been promptly disseminated and that no undisclosed material developments requiring mandatory disclosure have occurred.
Key Highlights
- Company confirms compliance with LODR and PIT regulations.
- No undisclosed material events requiring disclosure.
- All price-sensitive information has been disseminated.
- Reaffirms commitment to regulatory compliance.
Price Impact
More from ASTEC